Similar articles

• Multidrug resistance in breast cancer--is the jury in yet?

  Kaye SB. Kaye SB. J Natl Cancer Inst. 1997 Jul 2;89(13):902-3. doi: 10.1093/jnci/89.13.902. J Natl Cancer Inst. 1997. PMID: 9214663 No abstract available.
• Roles of multidrug resistance genes in breast cancer chemoresistance.

  Kuo MT. Kuo MT. Adv Exp Med Biol. 2007;608:23-30. doi: 10.1007/978-0-387-74039-3_2. Adv Exp Med Biol. 2007. PMID: 17993230 Review.
• Why does chemotherapy stop affecting the cells of ovarian and breast tumors?

  Kalinina EV, Chernov NN. Kalinina EV, et al. Future Oncol. 2018 May;14(12):1137-1140. doi: 10.2217/fon-2018-0001. Epub 2018 Apr 9. Future Oncol. 2018. PMID: 29629566 No abstract available.
• Molecular markers of multiple drug resistance in breast cancer.

  O'Driscoll L, Clynes M. O'Driscoll L, et al. Chemotherapy. 2006;52(3):125-9. doi: 10.1159/000092540. Epub 2006 Apr 4. Chemotherapy. 2006. PMID: 16612055 Review.
• Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.

  Feng X, Zhao L, Gao S, Song X, Dong W, Zhao Y, Zhou H, Cheng L, Miao X, Jia L. Feng X, et al. Gene. 2016 Mar 10;578(2):232-41. doi: 10.1016/j.gene.2015.12.028. Epub 2015 Dec 14. Gene. 2016. PMID: 26701615